TEL : 028-85121781
Set Homepage | Add Favorite     中文 | English
Chlorogenic Acid Mechanism Research Team

Study Leader for the Mechanism of Tumor Cell Apoptosis


Dr. JIANG Jiandong

Director of Institue of Materia Medica

Chinese Academy of Medical Sciences

Researcher,Doctoral Tutor

Mainly engaged in antiviral, antimetabolic disease and anti-tumor new drug research.

From 1989 to 1999, he worked at Mount Sinai School of Medicine at NYU. After returning to China, he worked at Institute of Medical Biotechnology, Chinese Academy of Medical Sciences. He has successively been a researcher, doctoral tutor, assistant director, vice director and director.

In December 2010, he was appointed director of Institute of Materia Medica, Chinese Academy of Medical Sciences.

In 2012, he became the first president of Medicine Research Academy, Chinese Academy of Medical Science, which is composed of Institue of Materia Medica, Institute of Medical Biotechnology and Institute of Medicinal Plant Development.

He is currently editor-in-chief of Acta Pharmaceutica Sinica B and member of the Academic Degrees Committee of the State Council.

Part-time: Vice President of China Pharmaceutical industry Research and Development Association; Managing Director of Chinese Pharmacological Society.

Director of Study on Immune Antitumor Mechanisms


Dr. CHEN Xiaoguang

Researcher,Doctor Tutor

Mainly engaged in anti-tumor drug molecular pharmacology research, new drug creation and development, research and development of Immunomodulatory Agents.

Committee member of China Anti-Cancer Association

Vice director of the Committee on Molecular and Biochemical Pharmacology, Chinese Pharmacological Society

Vice director of the Committee on Anti-tumor Drugs, Chinese Pharmaceutical Association

Member of the Committee of Marine Drugs, Chinese Pharmaceutical Association

Director of the Committee of Applied Pharmacology, Beijing Pharmaceutical Association

Assessment expert of “11th-Five-Year Plan” and “12th-Five-Year Plan” for major new drug creation project of Ministry of Science and Technology of the People's Republic of China

CFDA (China Food and Drug Administration) New Drug Assessment Expert Bank Member, CFDA Health Product Assessment Expert

Assessment Expert of New Pharmaceutical Project of Beijing Pharma and Biotech Center

Member of the academic degree evaluation committee of Institute of Materia Medica, Chinese Academy of Medical Sciences

Member of the Academic Committee of the Institute of Institute of Materia Medica, Chinese Academy of Medical Sciences

Editorial Board Member of Chinese Journal of Oncology

In 2004, she was awarded the first group of national-level candidates for the new century's millions of talents project.